Functionally, the expression of TIGIT was associated with TIL hypofunction [102], suggesting that an anti-TIGIT therapy may have potential for therapeutic use in mesothelioma [102], and a number of clinical trials and anti-TIGIT therapies are in progress [103]. The gene discussed is TIGIT; the disease is mesothelioma.